Antibacterial Activity of LCB10-0200 against <i>Klebsiella pneumoniae</i>
<i>Klebsiella pneumoniae</i> is one of the important clinical organisms that causes various infectious diseases, including urinary tract infections, necrotizing pneumonia, and surgical wound infections. The increase in the incidence of multidrug-resistance <i>K. pneumoniae</i>...
Main Authors: | Sang-Hun Oh, Young-Rok Kim, Hee-Soo Park, Kyu-Man Oh, Young-Lag Cho, Jin-Hwan Kwak |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/10/10/1185 |
Similar Items
-
In Vitro Activity of a Novel Siderophore-Cephalosporin LCB10-0200 (GT-1), and LCB10-0200/Avibactam, against Carbapenem-Resistant <em>Escherichia coli</em>, <em>Klebsiella pneumoniae</em>, <em>Acinetobacter baumannii</em>, and <em>Pseudomonas aeruginosa</em> Strains at a Tertiary Hospital in Korea
by: Le Phuong Nguyen, et al.
Published: (2021-04-01) -
In Vivo Activity of LCB 01-0699, a Prodrug of LCB 01-0648, against Staphylococcus aureus
by: Sang-Hun Oh, et al.
Published: (2017-11-01) -
In Vitro Activities of LCB 01-0648, a Novel Oxazolidinone, against Gram-Positive Bacteria
by: Sang-Hun Oh, et al.
Published: (2017-03-01) -
General Overview of <i>Klebsiella pneumonia</i>: Epidemiology and the Role of Siderophores in Its Pathogenicity
by: Rim Abbas, et al.
Published: (2024-01-01) -
In Vitro Activity of a Novel Siderophore-Cephalosporin, GT-1 and Serine-Type β-Lactamase Inhibitor, GT-055, against <i>Escherichia coli</i>, <i>Klebsiella pneumoniae</i> and <i>Acinetobacter</i> spp. Panel Strains
by: Le Phuong Nguyen, et al.
Published: (2020-05-01)